Objective. Students will describe how the sympathetic and parasympathetic divisions of the autonomic nervous system alter heart rate and contractility, and explain how common cardiovascular medications (rate-controlling agents) exploit these pathways.
This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.
VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.
Your heart does not beat because you decide to make it beat. The autonomic nervous system (ANS) runs that job automatically, moment to moment, without any conscious effort. As an EKG technician, you will watch heart rate and rhythm change in real time. Understanding why those changes happen — and how common medications influence them — makes you a sharper observer and a safer member of the care team.
The ANS has two divisions that act as opposites: the sympathetic division and the parasympathetic division. Both send nerve fibers directly to the heart.
The sympathetic division prepares the body for activity and stress. Its nerve fibers reach the heart through the cardiac accelerator nerves. When stimulated, these nerves release the neurotransmitter norepinephrine, which binds to beta-1 adrenergic receptors on cardiac tissue.
The result is a predictable cluster of effects:
The hormone epinephrine (adrenaline), released from the adrenal medulla during stress, mimics these same effects by binding to the same beta-1 receptors. This is why a frightened or exercising patient will show sinus tachycardia on your monitor.
The parasympathetic division slows the heart down and conserves energy. The primary pathway to the heart runs through the vagus nerve (cranial nerve X). When activated, the vagus nerve releases the neurotransmitter acetylcholine, which binds to muscarinic receptors on the SA node and AV node.
The effects are the mirror image of sympathetic stimulation:
High vagal tone is normal during sleep and in well-trained athletes. Sudden vagal surges — from bearing down, vomiting, or carotid sinus pressure — can cause a dramatic but usually brief drop in heart rate visible on the monitor.
Beyond direct nerve fibers, circulating hormones fine-tune cardiac function. Epinephrine and norepinephrine from the adrenal medulla amplify sympathetic effects throughout the body. Thyroid hormones increase the sensitivity of the heart to catecholamines, which is why hyperthyroid patients often show persistent tachycardia. These hormonal signals explain why conditions far from the heart — an overactive thyroid, a severe infection, blood loss — all show up as rhythm changes you can see on the EKG strip.
Rate-controlling medications used in cardiac patients work by targeting the exact receptors and channels described above. As an EKG technician, you will not prescribe or administer any of these agents — that is outside your scope of practice. Your role is to observe the tracing, report findings accurately, and recognize that a patient's medication history can explain what you see on the monitor.
Beta-blockers (e.g., metoprolol, atenolol) block beta-1 adrenergic receptors. They reduce sympathetic stimulation at the SA and AV nodes, slowing heart rate and lengthening the PR interval. On the monitor, expect a slower, steadier rate.
Non-dihydropyridine calcium channel blockers (e.g., diltiazem, verapamil) reduce the flow of calcium ions into SA and AV nodal cells, which slows spontaneous depolarization and depresses conduction. The clinical effect is similar to beta-blockade: slower rate, longer PR interval, and reduced contractility.
Atropine works on the parasympathetic side. It is a muscarinic receptor antagonist — it blocks acetylcholine's effect at the SA and AV nodes. With parasympathetic braking removed, sympathetic tone dominates and heart rate increases. Atropine is used clinically to treat symptomatic bradycardia. On the monitor, you will see the rate climb after administration.
Knowing how these drugs work does not authorize you to make treatment decisions. If you observe an unexpected rhythm change — sudden bradycardia, a new AV block, a rate that climbs after a medication is given — your duty is to:
1. Confirm lead placement and artifact are not the cause.
2. Report the finding promptly and accurately to the supervising nurse or clinician.
3. Document what you observed and when.
Never adjust a medication dose, suggest a medication, or delay reporting to investigate further on your own. Patient safety depends on fast, accurate communication within the team.
Answer each question, then check it. Nothing is recorded; this is your own practice.
A free tech program — complimentary, as our commitment to get America working. Help us build VoTechWorks. Tell us what works, what doesn’t, and what you want to learn.